Sfoglia per Autore
Molecular profiling of blastic plasmacytoid dendritic cell neoplasm reveals a unique pattern and suggests selective sensitivity to NF-kB pathway inhibition
2014 Sapienza, M R; Fuligni, F; Agostinelli, C; Tripodo, C; Righi, S; Laginestra, M A; Pileri, A; Mancini, M; Rossi, M; Ricci, F; Gazzola, A; Melle, F; Mannu, C; Ulbar, F; Arpinati, M; Paulli, M; Maeda, T; Gibellini, D; Pagano, L; Pimpinelli, N; Santucci, M; Cerroni, L; Croce, C M; Facchetti, F; Piccaluga, P P; Pileri, S A; and for the AIRC 5xMille consortium ‘Genetics-driven targeted management of lymphoid malignancies’ and the Italian Registry on Blastic Plasmacytoid Dendritic Cell Neoplasm
Low-Dose Anti-T Lymphoglobulin as Prophylaxis for Graft-versus-Host Disease in Unrelated Donor Transplantations for Acute Leukemias and Myelodysplastic Syndromes.
2018 Bonifazi F, Olivieri J, Sessa M, Dan E, Sinigaglia B, Rizzi S, Motta MR, Bontadini A, Ulbar F, Giudice V, Papayannidis C, Curti A, Chiereghin A, Lazzarotto T, Cavo M, Arpinati M.
Regulatory T cells from patients with end-stage organ disease can be isolated, expanded and cryopreserved according good manufacturing practice improving their function
2019 Ulbar F.; Montemurro T.; Jofra T.; Capri M.; Comai G.; Bertuzzo V.; Lavazza C.; Mandelli A.; Vigano M.; Budelli S.; Bacalini M.G.; Pirazzini C.; Garagnani P.; Giudice V.; Sollazzo D.; Curti A.; Arpinati M.; La Manna G.; Cescon M.; Pinna A.D.; Franceschi C.; Battaglia M.; Giordano R.; Catani L.; Lemoli R.M.
Process development and validation of expanded regulatory T cells for prospective applications: an example of manufacturing a personalized advanced therapy medicinal product
2022 Lavazza C.; Budelli S.; Montelatici E.; Vigano M.; Ulbar F.; Catani L.; Cannone M.G.; Savelli S.; Groppelli E.; Lazzari L.; Lemoli R.M.; Cescon M.; La Manna G.; Giordano R.; Montemurro T.
| Titolo | Autore(i) | Anno | Periodico | Editore | Tipo | File |
|---|---|---|---|---|---|---|
| Molecular profiling of blastic plasmacytoid dendritic cell neoplasm reveals a unique pattern and suggests selective sensitivity to NF-kB pathway inhibition | Sapienza, M R; Fuligni, F; Agostinelli, C; Tripodo, C; Righi, S; Laginestra, M A; Pileri, A; Manc...ini, M; Rossi, M; Ricci, F; Gazzola, A; Melle, F; Mannu, C; Ulbar, F; Arpinati, M; Paulli, M; Maeda, T; Gibellini, D; Pagano, L; Pimpinelli, N; Santucci, M; Cerroni, L; Croce, C M; Facchetti, F; Piccaluga, P P; Pileri, S A; and for the AIRC 5xMille consortium ‘Genetics-driven targeted management of lymphoid malignancies’ and the Italian Registry on Blastic Plasmacytoid Dendritic Cell Neoplasm | 2014-01-01 | LEUKEMIA | - | 1.01 Articolo in rivista | - |
| Low-Dose Anti-T Lymphoglobulin as Prophylaxis for Graft-versus-Host Disease in Unrelated Donor Transplantations for Acute Leukemias and Myelodysplastic Syndromes. | Bonifazi F, Olivieri J, Sessa M, Dan E, Sinigaglia B, Rizzi S, Motta MR, Bontadini A, Ulbar F, Gi...udice V, Papayannidis C, Curti A, Chiereghin A, Lazzarotto T, Cavo M, Arpinati M. | 2018-01-01 | BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION | - | 1.01 Articolo in rivista | - |
| Regulatory T cells from patients with end-stage organ disease can be isolated, expanded and cryopreserved according good manufacturing practice improving their function | Ulbar F.; Montemurro T.; Jofra T.; Capri M.; Comai G.; Bertuzzo V.; Lavazza C.; Mandelli A.; Viga...no M.; Budelli S.; Bacalini M.G.; Pirazzini C.; Garagnani P.; Giudice V.; Sollazzo D.; Curti A.; Arpinati M.; La Manna G.; Cescon M.; Pinna A.D.; Franceschi C.; Battaglia M.; Giordano R.; Catani L.; Lemoli R.M. | 2019-01-01 | JOURNAL OF TRANSLATIONAL MEDICINE | - | 1.01 Articolo in rivista | Ulbar et al_J Transl Med 2019.pdf |
| Process development and validation of expanded regulatory T cells for prospective applications: an example of manufacturing a personalized advanced therapy medicinal product | Lavazza C.; Budelli S.; Montelatici E.; Vigano M.; Ulbar F.; Catani L.; Cannone M.G.; Savelli S.;... Groppelli E.; Lazzari L.; Lemoli R.M.; Cescon M.; La Manna G.; Giordano R.; Montemurro T. | 2022-01-01 | JOURNAL OF TRANSLATIONAL MEDICINE | - | 1.01 Articolo in rivista | Lavazza C et al_J Transl Med_2022.pdf; 12967_2021_3200_MOESM1_ESM.docx |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile